Physician profile
Jessica Minjy Kang
NPI 1891184669
$37,078.20
in general payments reported to CMS, 2019-2025
5 companies · $18K in 2025
The $18K reported for 2025 was more than what 95% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.47 · 2022: $127 · 2023: $203 · 2024: $19K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,250 · Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $31,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,250.00 |
| Food and Beverage | $937.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $31,500.00 | 2024-2025 | |
| Alcon Vision LLC | $4,523.56 | 2023-2025 | Hydrus Microstent |
| New World Medical,INC. | $720.25 | 2024-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Abbvie INC. | $220.59 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $113.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.